Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Promising phase II results reported for BTI-322 in GVHD

July 21, 1998

Ribi acquires new adjuvant technology from U of Nebraska

July 21, 1998

Human vaccination study demonstrates potential of oral and nasal MaxVax

July 20, 1998

Promising immunosuppressive activity reported for KF-20444

July 17, 1998

In vitro and in vivo studies with VX-497 reported at transplant congress

July 17, 1998

Pasteur Merieux Connaught, Cistron Biotechnology collaborate on vaccine adjuvant development

July 17, 1998

Clinical evaluation of AlloMune transplantation system begins

July 15, 1998

Italian launch for Prograf announced

July 15, 1998

WF10, a unique AIDS treatment alternative evaluated in the clinic

July 13, 1998

Immunosuppressive potassium channel blockers from Merck & Co.

July 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...